Palantir ($PLTR) is suffering its worst month since August 2023. The stock has already fallen about 15% in November, wiping out nearly $90 billion in market value. Since November 3, 2025, shares have ...

Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line settingIn the ...

Excerpts from recent editorials in the United States and abroad:___Nov. 17The Wall Street Journal on Trump, Gaza and the U.N. Security CouncilMaybe the United Nations isn’t as useless as it so often ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the appointment of José Iglesias, M.D. as Chief Medical Affairs Officer, effective November 10, 2025. Dr. Iglesias ...

The FTSE 100 (^FTSE) and European stocks tumbled on Tuesday as the boss of Google (GOOG) warned that every company in the world could take a hit if a bubble in AI stocks burst. Speaking to BBC News, ...

Wall Street retreated again on Tuesday as data showed US private sector job losses had slowed at the end of October. The FTSE ...